InnovationRx: Positive Clinical Trial Results For Generative AI-Designed Drug
Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.
The American Journal of Managed Care18h
Liver Fibrosis Scores May Hint at Heart Failure Risk
Noninvasive liver fibrosis scores are associated with increased heart failure risk, with FIB-4, NFS, and APRI showing ...
Aileron Therapeutics' Investigational Drug Shows Encouraging Action In Lung Fibrosis
Aileron Therapeutics' Phase 1b trial shows LTI-03 improved biomarkers and reduced SPD levels, indicating the potential to ...
Aileron Therapeutics Reports Positive Phase 1b Data Of LTI-03 In Idiopathic Pulmonary Fibrosis
(RTTNews) - Aileron Therapeutics, Inc. (ALRN), Wednesday announced positive topline data from the cohort 2 of Phase 1b study evaluating LTI-03 in patients with idiopathic pulmonary fibrosis (IPF).
You should be paying more attention to your lungs. KU Med is helping you do it | Opinion
Survival rates for idiopathic pulmonary fibrosis are worse than all solid cancers except for lung and pancreatic cancer. | ...
WBUR1d
My patients shouldn’t have to endure ‘air hunger’
As physicians we take an oath to do no harm, yet are trapped providing care in a system that leaves patients confined and at ...
FierceBiotech1d
Insilico's AI-designed med tied to respiratory health improvements in midstage lung disease trial
Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...
pulmonaryfibrosisnews1d
To my IPF community: Now is the time for legislative advocacy
Columnist Sam Kirton encourages the IPF community to get a jump on legislative advocacy before the new congressional term begins.